epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aralen
    chloroquine phosphate
  • remove Clarinex Reditabs
    desloratadine
  • remove Jascayd
    nerandomilast

multicheck MultiCheck Results - 0 Interaction

Smiley face Smiley face

Additional Considerations

Smiley face Smiley face chloroquine in Aralen

consider monitoring ECG in combo with other drugs that prolong QT interval; combo may incr. risk of QT prolongation, cardiac arrhythmias, even after chloroquine D/C due to long half-life (1-2mo)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information